Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Patient-reported outcomes and clinical disability outcomes in Multiple Sclerosis (MS) demonstrate the same rates of worsening when performed in, neurology clinic, patient registry and a clinical trial.

The assessment of inflammation markers IL-1beta and IL-6 before and after FMT in patients with Parkinson’s disease.

Role of the Pharmacist in Monitoring Patients Receiving Oral Edaravone for Amyotrophic Lateral Sclerosis